Follow-Up of Advanced Parkinson’s Disease Patients after Clinical or Surgical Emergencies: A Practical Approach

Table 2

Demographic and clinical description of advanced PD cases with clinical and surgical emergencies treatment.

Case	Age (years)	Gender	PD duration (years)	Acute event	Complication	Baseline off UPDRS III score	Levodopa dose	Other inhospital drugs	Levodopa management	Follow-up off UPDRS III	Follow-up H&Y scale
1	78	F	15	Acute diverticulitis	Delirium, acute peritonitis	43	Withdrawn	Bromopride	Sublingual	53	V
2	75	M	20	Femur fracture	Delirium	39	Withdrawn	Opioid, risperidone	Oral restarted	50	V
3	79	M	18	Broncho pneumonia	Delirium, lung abscess	43	Reduced	Opiod	Oral optimized	54	V
4	80	M	20	Acute myocardial infarction	Delirium, cardiogenic shock	44	Unchanged	Trimetazidine	None	55	V
5	77	F	16	Mesenteric thrombosis	Delirium	39	Withdrawn	Opioid	OG tube	59	V
6	74	M	14	Femur fracture	Delirium	38	Withdrawn	Opioid, levomepromazine	OG tube	48	V
7	73	M	17	Femur fracture	Delirium	42	Withdrawn	Opioid, promethazine	OG tube	52	V
8	72	F	13	Pulmonary embolism	Delirium, acute respiratory insufficiency	37	Unchanged	None	None	48	V
9	75	M	14	Acute diverticulitis	Delirium	38	Unchanged	Risperidone	Sublingual	50	V
10	79	F	16	Urinary tract infection	Delirium, sepsis	36	Reduced	None	Oral optimized	47	V
11	78	F	14	Femur fracture	Delirium	43	Reduced	Opiod, amlodipine	OG tube	53	V
12	74	M	13	Colonic pseudoobstruction	Delirium	38	Withdrawn	Neostigmine	Sublingual	52	V
13	85	M	15	Upper airway infection	Delirium	38	Reduced	Bromopride, haloperidol	Oral optimized	49	V

PD = Parkinson’s disease; H&Y  =  Hoehn & Yahr stage, and UPDRS = Unified Parkinson’s Disease Rating Scale.